<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05082597</url>
  </required_header>
  <id_info>
    <org_study_id>CF21163B</org_study_id>
    <nct_id>NCT05082597</nct_id>
  </id_info>
  <brief_title>Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome</brief_title>
  <official_title>Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome-A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taichung Veterans General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Axillary web syndrome(AWS) is common complication of breast cancer surgery. Overall, AWS&#xD;
      affects more than a half of the patient receiving axillary lymph node dissection. The&#xD;
      symptoms of AWS include pain, limited function and range of motion. Geater risk of secondary&#xD;
      lymphedema was found if the patient developed AWS during the first postoperative year.&#xD;
&#xD;
      ESWT was used for treating myofascial pain for decades. Low energy ESWT combined with complex&#xD;
      decongestive therapy had a benefit on shoulder joint ROM and skin thickness improvement in&#xD;
      patients with BCRL in recently studies. Investigators wonder if ESWT can also be applied to&#xD;
      patients with axillary web syndrome for increasing ROM and relieving pain.&#xD;
&#xD;
      The aim of this study was to evaluate the therapeutic effects of low energy ESWT in patients&#xD;
      with axillary web syndrome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 13, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Shoulder range of motion</measure>
    <time_frame>2 months</time_frame>
    <description>Flexion, extension, external rotation, internal rotation, abduction over upper limbs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain score</measure>
    <time_frame>2 months</time_frame>
    <description>Visual Analogue Scale (0-10 points, higher score represented higher degree of pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>2 months</time_frame>
    <description>Muscle strength of upper limb measured by ergometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper limb functional score</measure>
    <time_frame>2 months</time_frame>
    <description>quick Disabilities of the Arm, Shoulder and Hand Score(qDASH) (0-100 points, higher score indicated higher level of upper limb impairment)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Axillary Web Syndrome</condition>
  <condition>Breast Cancer</condition>
  <condition>Lymphedema</condition>
  <condition>Extracorporeal Shock Wave Therapy</condition>
  <arm_group>
    <arm_group_label>ESWT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive low energy extracorporeal shock wave therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low energy ESWT</intervention_name>
    <description>Therapeutic sessions: 4(once a week, for 4 weeks) Total dosage: 2500 shoots over axillary cord lesion (1000 over most fibrotic area, 500 over upper arm, 500 over forearm, 500 over other area) Energy: 0.056-0.065mJ/mm2</description>
    <arm_group_label>ESWT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Axillary web syndrome patient&#xD;
&#xD;
          2. Unilateral breast cancer and received related operation(mastectomy/ALND/SLND)&#xD;
&#xD;
          3. Completion of beast related chemotherapy or radiotherapy&#xD;
&#xD;
          4. Age with 20-65 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Ongoing metastasis or recurrence of the breast cancer&#xD;
&#xD;
          2. Other cancer history&#xD;
&#xD;
          3. Lymphatic transplantation or reconstruction&#xD;
&#xD;
          4. Wound, infection or trauma over affected arm&#xD;
&#xD;
          5. Coagulopathy or poor circulation&#xD;
&#xD;
          6. Pregnancy&#xD;
&#xD;
          7. Oral anticoagulant using&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yuan Yang Cheng, MD,PhD</last_name>
    <phone>+8864-2359-2525</phone>
    <phone_ext>3500</phone_ext>
    <email>yycheng@vghtc.gov.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yu Chun Lee, MD, MHA</last_name>
    <phone>+8864-2359-2525</phone>
    <phone_ext>3507</phone_ext>
    <email>lyczoj@vghtc.gov.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung</city>
        <state>Republic Of China(R.O.C)</state>
        <zip>40705</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuan Yang Cheng, MD, PhD</last_name>
      <phone>+886423592525</phone>
      <phone_ext>3500</phone_ext>
      <email>yycheng@vghtc.gov.tw</email>
    </contact>
    <contact_backup>
      <last_name>Yu Chun Lee, MD, MHA</last_name>
      <phone>+886423592525</phone>
      <phone_ext>3507</phone_ext>
      <email>lyczoj@vghtc.gov.tw</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 24, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

